Ikarian Capital, LLC Fate Therapeutics Inc Put Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $598,525 - $823,428	-8,900 Reduced 8.17%	100,000 $8.68 Million
Q1 2021 May 17, 2021	BUY	$72.16 - $117.4 $5.06 Million - $8.23 Million	70,100 Added 180.67%	108,900 $8.98 Million
Q4 2020 Feb 12, 2021	SELL	$38.09 - $100.95 $430,417 - $1.14 Million	-11,300 Reduced 22.55%	38,800 $3.53 Million
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $865,728 - $1.6 Million	50,100 New	50,100 $1.11 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $182M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.